• About
    • About the Event
    • Attendee Profile
    • Key Contacts
    • Media Gallery
    • Testimonials
  • Agenda
    • Search Agenda
    • Programs
    • Plenary Sessions
    • Speaker Biographies
    • Short Courses
    • Breakout Discussions
    • Brochures
  • Sponsor/Exhibit
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Sponsor/Exhibitor Prospectus
    • Exhibit Floorplan
    • Exhibit Kit
    • Lead Generation Opportunities
  • Travel
  • Posters
    • Poster Info
    • Poster Titles
  • Media
    • Media Partners
    • Newsroom
    • Press Pass
  • Register
    • Individual Pricing
    • Group Pricing
    • On-Demand Pricing
    • Press Pass
OPT Congress - Oligonucleotide & mRNA Therapeutics

Oligonucleotide Conference Programs

Oligo Discovery & Delivery

Oligo CMC & Regulatory Strategies

mRNA Design & Delivery

Emerging Oligo Modalities


Short Courses | Tuesday, March 11 | In-Person Only

Safety & Toxicity of Nucleic Acids


Successful Regulatory Submission for a Complex Oligonucleotide

Search Agenda



CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy